VOM V

VOM V

VOM V is a cross-linked hyaluronic acid dermal filler from CGBio, South Korea. It is the softest gel in the VOM range, designed for injection into the mid dermis for the correction of fine lines. It contains 0.3% lidocaine to improve comfort during injection. Each box contains two 1.0 ml pre-filled syringes with 27G½ and 30G½ needles. For use by licensed physicians only.

主要特点

• Softest Gel in the Range: Designed for fine lines in the mid dermis.
• Cross-Linked Hyaluronic Acid: 20 mg/ml. According to the manufacturer, the gel has a multi-layered phasic structure, in which a cross-linked HA gel surrounds cross-linked HA particles, and is produced with CGBio’s R² (Rotation & Revolution) technology.
• With 0.3% Lidocaine: Helps reduce discomfort during injection.
• 可逆：由具备资质的专业人员使用透明质酸酶，即可溶解透明质酸。

The VOM Range

The VOM range includes three fillers with different gel firmness, all at 20 mg/ml HA. The physician selects the product according to the treatment area and tissue depth.

• VOM V: The softest gel, for fine lines, injected into the mid dermis.
• VOM O: For deeper wrinkles and folds, injected into the deep dermis.
• VOM M: The firmest gel, for volume and contour, injected into the subcutaneous layer.

预期用途

• Fine lines around the eyes, including crow’s feet
• Fine lines around the mouth and lip contour
• Fine lines of the neck

Treatment area, injection depth, technique and volume must follow the official Instructions for Use and the treating physician’s assessment. Results and duration vary between individuals.

产品规格

• 品牌： VOM
• Product: VOM V
• Company: CGBio Co., Ltd.
• 起源： South Korea
• Composition: Cross-linked hyaluronic acid 20 mg/ml, lidocaine hydrochloride 0.3%
• Injection Depth: Mid dermis
• Contents: 2 × 1.0 ml pre-filled syringes, 27G½ and 30G½ needles
• Shelf Life: Refer to the carton for the expiry date.
• 产品类型： Hyaluronic acid dermal filler (medical device)

施用

• For use only by licensed physicians trained in facial anatomy, filler injection techniques and the management of filler complications.
• Check that the packaging is intact and the product is within its expiry date before use.
• Inject under aseptic conditions at the depth specified in the IFU. Inject slowly in small amounts with low pressure.
• Not intended for deep folds, volume restoration or contour. Other products in the range are designed for these indications. In thin skin such as the periorbital area and neck, placement that is too superficial may result in visible lumps or a bluish discolouration.
• Confirm the patient has no allergy to lidocaine or other amide-type local anaesthetics before use.
• Each syringe is for a single patient. Injection technique, volume and treatment interval must follow the IFU and the treating physician’s judgment.
• Do not self-administer.

禁忌症

General contraindications for hyaluronic acid fillers containing lidocaine are listed below. Refer to the official Instructions for Use for the complete list.

• Known hypersensitivity to hyaluronic acid, lidocaine or other amide-type local anaesthetics
• History of severe allergies or anaphylaxis
• Active infection, inflammation, wounds or skin disease at or near the injection site
• 怀孕或哺乳期
• Persons under 18 years of age

Who Should Consult a Physician First

• People with autoimmune disease, diabetes or epilepsy
• People with bleeding disorders or taking anticoagulant or antiplatelet medication
• People with a history of cold sores (herpes labialis), especially before treatment around the mouth or lips
• People with a tendency to hypertrophic scars or keloids
• People with heart rhythm disorders, severe liver disease or porphyria
• People with permanent fillers or implants in the treatment area

防范措施

• Common reactions include redness, swelling, pain, tenderness, itching and bruising at the injection site.
• Lumps, nodules, asymmetry, bluish discolouration, product migration, infection and delayed inflammatory reactions may occur.
• Accidental injection into a blood vessel can cause vascular occlusion, skin necrosis and, rarely, visual impairment or blindness. The periorbital area and the lips contain arteries that require particular care.
• Hyaluronic acid can be dissolved with hyaluronidase. Practitioners should keep hyaluronidase and an emergency protocol available.
• Seek medical attention immediately for severe or increasing pain, skin blanching or colour change, or any change in vision after treatment.
• Do not use if the packaging is open or damaged, the syringe is cracked or the product is past its expiry date.
• Single use only. One syringe, one patient. Do not re-sterilise. Keep out of reach of children.

After Treatment

Follow the aftercare instructions given by the treating physician. Strenuous exercise, heat exposure and pressure on the treated area are generally avoided for the first 24 hours. Report any adverse reaction to the treating physician.

贮存

Store at 2–25°C. Protect from direct sunlight and freezing. Refer to the carton for storage conditions and the expiry date.

Package Contents

• 2 × 1.0 ml pre-filled syringes of VOM V
• 27G½ and 30G½ needles
• Instructions for Use

重要通知

For professional healthcare use only. This information is for general product reference. It does not replace medical advice, the official Instructions for Use or local regulations. This product is not intended to diagnose, treat, cure or prevent any disease. Results vary between individuals.